A detailed history of Avantax Planning Partners, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 7,167 shares of MDT stock, worth $580,742. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,167
Previous 8,155 12.12%
Holding current value
$580,742
Previous $641,000 0.62%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.84 - $91.03 $75,917 - $89,937
-988 Reduced 12.12%
7,167 $645,000
Q2 2024

Aug 09, 2024

BUY
$78.71 - $87.02 $16,135 - $17,839
205 Added 2.58%
8,155 $641,000
Q1 2024

May 02, 2024

BUY
$82.84 - $88.09 $160,958 - $171,158
1,943 Added 32.35%
7,950 $692,000
Q4 2023

Feb 09, 2024

SELL
$69.43 - $83.43 $21,870 - $26,280
-315 Reduced 4.98%
6,007 $494,000
Q3 2023

Nov 03, 2023

BUY
$78.22 - $90.4 $15,096 - $17,447
193 Added 3.15%
6,322 $495,000
Q2 2023

Jul 17, 2023

BUY
$79.47 - $91.38 $2,304 - $2,650
29 Added 0.48%
6,129 $539,000
Q1 2023

Apr 20, 2023

SELL
$76.72 - $87.58 $38,360 - $43,790
-500 Reduced 7.58%
6,100 $491,000
Q4 2022

Feb 09, 2023

BUY
$76.18 - $87.74 $10,741 - $12,371
141 Added 2.18%
6,600 $513,000
Q3 2022

Oct 14, 2022

BUY
$80.75 - $95.31 $3,391 - $4,003
42 Added 0.65%
6,459 $522,000
Q2 2022

Jul 18, 2022

SELL
$87.4 - $113.09 $65,899 - $85,269
-754 Reduced 10.51%
6,417 $576,000
Q1 2022

May 09, 2022

SELL
$100.58 - $112.38 $12,572 - $14,047
-125 Reduced 1.71%
7,171 $796,000
Q4 2021

Jan 28, 2022

SELL
$99.53 - $127.75 $6,867 - $8,814
-69 Reduced 0.94%
7,296 $755,000
Q3 2021

Oct 27, 2021

BUY
$122.75 - $135.17 $24,181 - $26,628
197 Added 2.75%
7,365 $923,000
Q2 2021

Aug 10, 2021

BUY
$118.19 - $131.5 $4,136 - $4,602
35 Added 0.49%
7,168 $890,000
Q1 2021

May 06, 2021

BUY
$111.18 - $119.74 $25,904 - $27,899
233 Added 3.38%
7,133 $843,000
Q4 2020

Feb 04, 2021

SELL
$100.57 - $117.14 $27,254 - $31,744
-271 Reduced 3.78%
6,900 $808,000
Q3 2020

Oct 28, 2020

BUY
$90.13 - $108.78 $37,223 - $44,926
413 Added 6.11%
7,171 $745,000
Q2 2020

Jul 15, 2020

SELL
$84.11 - $103.33 $672 - $826
-8 Reduced 0.12%
6,758 $620,000
Q1 2020

Apr 27, 2020

SELL
$72.92 - $121.3 $7,802 - $12,979
-107 Reduced 1.56%
6,766 $610,000
Q4 2019

Jan 15, 2020

SELL
$104.49 - $114.54 $21,211 - $23,251
-203 Reduced 2.87%
6,873 $780,000
Q3 2019

Nov 08, 2019

BUY
$98.02 - $111.18 $214,173 - $242,928
2,185 Added 44.67%
7,076 $769,000
Q2 2019

Aug 07, 2019

BUY
$84.15 - $99.38 $39,129 - $46,211
465 Added 10.51%
4,891 $479,000
Q1 2019

May 08, 2019

SELL
$82.45 - $93.79 $70,082 - $79,721
-850 Reduced 16.11%
4,426 $403,000
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $12,097 - $14,028
141 Added 2.75%
5,276 $480,000
Q3 2018

Nov 13, 2018

BUY
$85.91 - $99.17 $91,837 - $106,012
1,069 Added 26.29%
5,135 $505,000
Q2 2018

Aug 13, 2018

SELL
$77.48 - $87.83 $123,735 - $140,264
-1,597 Reduced 28.2%
4,066 $348,000
Q1 2018

May 15, 2018

SELL
$76.55 - $87.26 $17,759 - $20,244
-232 Reduced 3.94%
5,663 $454,000
Q4 2017

Feb 09, 2018

SELL
$76.93 - $83.5 $45,619 - $49,515
-593 Reduced 9.14%
5,895 $476,000
Q3 2017

Oct 19, 2017

BUY
$77.71 - $84.6 $504,182 - $548,884
6,488
6,488 $505,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.